Showing results (71-80 of 171) with videos related to
Sort By:
Pageof 18
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitisLaurent Beaugerie, Michaela Metz, Frédéric Barbut, et al.Journal of Crohn'S & Colitis|August 29, 2024
The Groupe d'Etude sur les Affections Inflammatoires Digestives (GETAID): 40 Years of a Family Story in Inflammatory Bowel DiseaseDavid Laharie, Lucine Vuitton, Arnaud Bourreille, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 5, 2013
Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's diseaseJean-Frédéric Colombel, William J Sandborn, Matthieu Allez, et al.Drugs - Real World Outcomes|October 9, 2024
Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE StudyBruno Fautrel, Yoram Bouhnik, Carine Salliot, et al.Inflammatory Bowel Diseases|January 9, 2007
Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified)Vincent Maunoury, Guillaume Savoye, Arnaud Bourreille, et al.Clinics and Research in Hepatology and Gastroenterology|December 7, 2025
Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factorAurélien Amiot, Julien Kirchgesner, Hadrien Alric, et al.The American Journal of Gastroenterology|June 18, 2003
Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac diseaseKouroche Vahedi, Françoise Mascart, Jean Yves Mary, et al.Gut|August 25, 2022
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activityNicolas Pierre, Vân Anh Huynh-Thu, Thomas Marichal, et al.Clinical Rheumatology|March 23, 2026
Screening for osteoporosis in patients with inflammatory bowel diseases: a cross-sectional studySébastien Ottaviani, Xavier Tréton, Marine Forien, et al.Molecular Pharmaceutics|July 8, 2010
Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first passArnaud Bruyère, Xavier Declèves, Francois Bouzom, et al.Pageof 18